US 7621740
Mahonia aquifolium extract, extraction process and pharmaceutical composition containing the same
granted A61KA61K36/29A61K8/14
Quick answer
US patent 7621740 (Mahonia aquifolium extract, extraction process and pharmaceutical composition containing the same) held by Prime Pharmaceutical Corporation expires Mon Nov 19 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Prime Pharmaceutical Corporation
- Grant date
- Tue Nov 24 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 19 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 4
- CPC classes
- A61K, A61K36/29, A61K8/14, A61K8/9789, A61K9/0014